Streszczenie
2/2025
vol. 20
Artykuł przeglądowy
Exploring synergistic therapy for metabolic dysfunction-associated steatotic liver disease
- New York Presbyterian Brooklyn Methodist Hospital, New york, US
- Department of Medicine, University of Debrecen, Debrecen, Hungary
Gastroenterology Rev 2025; 20 (2): 115–120
Data publikacji online: 2025/06/06
Pełna treść artykułu
AMA
Zaher A, Elsaygh H. Exploring synergistic therapy for metabolic dysfunction-associated steatotic liver disease. Gastroenterology Review/Przegląd Gastroenterologiczny. 2025;20(2):115-120. doi:10.5114/pg.2025.151891.
APA
Zaher, A., & Elsaygh, H. (2025). Exploring synergistic therapy for metabolic dysfunction-associated steatotic liver disease. Gastroenterology Review/Przegląd Gastroenterologiczny, 20(2), 115-120. https://doi.org/10.5114/pg.2025.151891
Chicago
Zaher, Anas, and Hassan Elsaygh. 2025. "Exploring synergistic therapy for metabolic dysfunction-associated steatotic liver disease". Gastroenterology Review/Przegląd Gastroenterologiczny 20 (2): 115-120. doi:10.5114/pg.2025.151891.
Harvard
Zaher, A., and Elsaygh, H. (2025). Exploring synergistic therapy for metabolic dysfunction-associated steatotic liver disease. Gastroenterology Review/Przegląd Gastroenterologiczny, 20(2), pp.115-120. https://doi.org/10.5114/pg.2025.151891
MLA
Zaher, Anas et al. "Exploring synergistic therapy for metabolic dysfunction-associated steatotic liver disease." Gastroenterology Review/Przegląd Gastroenterologiczny, vol. 20, no. 2, 2025, pp. 115-120. doi:10.5114/pg.2025.151891.
Vancouver
Zaher A, Elsaygh H. Exploring synergistic therapy for metabolic dysfunction-associated steatotic liver disease. Gastroenterology Review/Przegląd Gastroenterologiczny. 2025;20(2):115-120. doi:10.5114/pg.2025.151891.
